Latest Trends on Lung Cancer Surgery Market to Reach US$ 29.99 Billion by 2021 Growing at 6.8% CAGR
Lung cancer surgery market is projected to reach USD 29.99 Billion by 2021 from USD 21.58 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. On basis of device, lung cancer surgery market is segmented into surgical instruments, monitoring and visualizi
(EMAILWIRE.COM, October 02, 2018 ) Major factors contributing to growth of global lung cancer surgery market include increasing incidence & prevalence of cancer, increasing lung cancer awareness campaigns, & rising aging population. Thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, thoracotomy segment is expected to account for largest share of market. Get Free Sample Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=844138 .
Lung cancer surgery market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population.
Target Audience for this Report:
• Manufacturers of Surgical Robots and Lasers
• Vendors and Distributors of Powered Surgical Instruments
• Hospitals
• Research Institutes Related to Cancer Studies
• Venture Capitalists and Investors
Geographically, North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.
Complete Report on Lung Cancer Surgery Market spread across 135 Pages, Profiling 11 Companies and Supported with 85 Tables and 44 Figures is now available at http://www.rnrmarketresearch.com/lung-cancer-surgery-market-by-procedure-thoracotomy-lobectomy-pneumonectomy-segmentectomy-minimally-invasive-device-surgical-clamps-forceps-retractors-stapler-monitoring-camera-trocar-endoscopic-i-st-to-2021-market-report.html .
On the other hand, high cost of lung cancer surgery is restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the lung cancer surgery market. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.
Premium Insights
1 Lung Cancer Surgical Devices Market Overview
2 Geographic Analysis: Lung Cancer Surgical Devices Market, By Type
3 Lung Cancer Surgical Procedures Market, By Type, 2016-2021
4 Lung Cancer Surgical Devices Market, By Region, 2016-2021
The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).
Connect for More Details for Discount and More Information “Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=844138 .
Research Coverage
This report provides insights into the global lung cancer surgery market. It provides valuable information on the devices, procedures, and regions in the lung cancer surgery market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market. The above-mentioned information would help the buyer understand market dynamics.
Lung cancer surgery market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population.
Target Audience for this Report:
• Manufacturers of Surgical Robots and Lasers
• Vendors and Distributors of Powered Surgical Instruments
• Hospitals
• Research Institutes Related to Cancer Studies
• Venture Capitalists and Investors
Geographically, North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.
Complete Report on Lung Cancer Surgery Market spread across 135 Pages, Profiling 11 Companies and Supported with 85 Tables and 44 Figures is now available at http://www.rnrmarketresearch.com/lung-cancer-surgery-market-by-procedure-thoracotomy-lobectomy-pneumonectomy-segmentectomy-minimally-invasive-device-surgical-clamps-forceps-retractors-stapler-monitoring-camera-trocar-endoscopic-i-st-to-2021-market-report.html .
On the other hand, high cost of lung cancer surgery is restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the lung cancer surgery market. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.
Premium Insights
1 Lung Cancer Surgical Devices Market Overview
2 Geographic Analysis: Lung Cancer Surgical Devices Market, By Type
3 Lung Cancer Surgical Procedures Market, By Type, 2016-2021
4 Lung Cancer Surgical Devices Market, By Region, 2016-2021
The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).
Connect for More Details for Discount and More Information “Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=844138 .
Research Coverage
This report provides insights into the global lung cancer surgery market. It provides valuable information on the devices, procedures, and regions in the lung cancer surgery market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market. The above-mentioned information would help the buyer understand market dynamics.
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results